July 21, 2016
AstraZeneca AB slammed Aurobindo Pharma Ltd. with a patent infringement lawsuit in New Jersey federal court on Wednesday over the generics maker's versions of Nexium, claiming the company should be barred from selling the drugs before AstraZeneca's patents and any additional periods of exclusivity expire.